Global Stem Cells Group Announces Members of Advisory Board to Speak at the Latin American A4M Anti-Aging Medicine Conference in Mexico City
Global Stem Cells Group, has announced that two GSCG Advisory Board members, Joseph Purita, M.D. and Gilberto Hernandez Falcon, M.D., will be keynote speakers at the Latin American Chapter of the American Academy of Anti-Aging Medicine (A4M) VII World Congress in Mexico City, Feb. 12, 13 and 14 2016.
MIAMI, Jan. 21, 2016—Global Stem Cells Group, a world leader in regenerative medicine, has announced that two members of its Advisory Board, Joseph Purita, M.D. and Gilberto Hernandez Falcon, M.D., will be keynote speakers at the American Academy of Anti-Aging Medicine (A4M) Latin American Chapter of the VII World Congress Feb. 12, 13 and 14 2016.
The conference will focus on recent technological and scientific advances in anti-aging medicine that are becoming indispensible in the prevention, prediction, detection, treatment and rehabilitation of diseases that occur with advancing age. This conference will focus on new treatments and protocols to extend years and improve patient quality of life.
Conference topics include recent protocols in weight control and obesity, platelet rich plasma therapies, menopause, sexual health and hormonal balance, alternative medicine for stress and sleep disorders, LED laser and thermal heat treatments, biodentical hormone replacement therapy and its clinical applications, oxygen and ozone therapies, recent advances in cellular therapies for cosmetic applications and much more.
Joseph Purita, M.D.
Purita, who heads the Global Stem Cells Group Advisory Board, is a pioneer in the use of stem cell therapies in orthopedics. He will speak on the latest advances in evidence-based, best-practice protocols for the early detection, prevention and treatment of medical problems associated with aging.
Gilberto Hernandez Falcon, M.D.,
The conference will be held at the Hotel Fiesta Americana Reforma in Mexico City.
For more information, visit the Global Stem Cells Group website, email info(at)stemcelltraining(dot)net, or call (305) 560-5337.
About Global Stem Cell Group:
Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
###
To view this press release live online, please click here
- Published in Press Releases
Global Stem Cells Announces the 2016 International Academic Year Inaugural Convention in Santiago, Chile
Global Stem Cells Group will present the largest global network of medical leaders and physicians from an array of disciplines and practices worldwide, as well as their representatives, franchises and partners at the 2016 International Academic Year Inaugural Convention March 25, 25 and 27 in Santiago, Chile.
MIAMI, Jan. 19, 2016—Global Stem Cells Group, a world leader in regenerative medicine, will host the 2016 International Academic Year Inaugural Convention March. 25-27, 2016 in Santiago, Chile. The convention will kick off the New Year by gathering the largest global network of medical leaders and physicians from around the world to formally sign a joint venture between GSCG and Santiago-based Cellus Regenerative Medicine, SA.
Global Stem Cells Group COO Kipp Van Camp will be in Santiago to execute the agreement between GSCG and Cellus, and to supervise GSCG’s new facilities and protocols to be used in its medical tourism initiative.
David Audley, Chair and General Secretary of the Regentech Alliance (RTA), will be on hand to conduct the GSCG Chile facility’s RTA certification process. The RTA certification signifies that GSCG Chile meets the highest standards of excellence in current medical and laboratory practices as measured by established standards.
The mission of the conference s to educate the medical community on the latest advances in regenerative medicine, and will feature experts in regenerative medicine, including:
Spain
• Augusti Molins, M.D. of the Medical Center in Barcelona. Molins specializes in nutrition and dietetics, the protein diet Sulço® method, obesity and overweight children, ozone therapy, carboxitherapy, aesthetic medicine cosmetic surgery. Spain.
U.S.• Kipp Van Kamp, D.O., interventional radiologist, Global Stem Cells Group COO, regenerative medicine expert. A graduate of Kansas City University of Physicians and Surgeons, affiliated with The Clara Barton Hospital Association Inc. in Hoisington, Kansas and Critical Imaging Associates in Topeka, Kansas.
.
Chile• Enrique Testart, M.D., trauma surgeon, pediatric microsurgeon, regenerative medicine specialist, surgeon/manager Innovassalud, S.A. German clinic in Santiago, founder, ConsortiaInnovas S.A., Global Stem Cells Group Chile CEODavid Audley, (U.S.) international consultant; fellow, Institute for Global Health and research, Chair, American Regenerative Technology Alliance (RTA).
.
U.S.• David Audley, international consultant; fellow, Institute for Global Health and research, Chair, American Regenerative Technology Alliance (RTA).
. Following the conference, Global Stem Cells Group will conduct a special training course to include regenerative medicine body preparations using vitamin combinations and other nutritional supplements to enhance stem cell function.
The conference will take place at the Marriott Hotel in Santiago, AV. Pdte. Kennedy 5741 –Vitacura.
For more information on the 2016 International Academic Year Inaugural Convention in Santiago, Chile visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com or call 305-224-1858.
About Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Cellus Regenerative Medicine, SA.:
Cellus is dedicated to research, development and commercialization of therapeutic services and custom biotech products in the field of regenerative medicine. Their multidisciplinary team of stem cell experts focuses on the prevention and reversal of impairment in the skin of patients with traumatic injuries, skin diseases or symptoms of aging.
Their state-of-the-art facility in Santiago features a full laboratory and showcases the company’s extensive clinical expertise and biopharmaceutical production capabilities.
To view this press release live online, click here.
###
- Published in Press Releases
- 1
- 2
